Angiotech is a global specialty pharmaceutical and medical device company that discovers, develops, and markets innovative technologies and medical products primarily for local diseases or for complications associated with medical device implants, surgical interventions and acute injury.

Acquired Companies: Cohesion Technologies, Neucoll, Inc., STS Biopolymers